Catalyst Wire Dossier Catalyst Wire Dossier

Gemcitabine-based chemotherapy

gemcitabine · Eli Lilly and Company
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Gemcitabine-based chemotherapy, covering 2024-12-10 to 2024-12-10. Get the full timeline:

Most recent: Clinical Trial Update: Adjuvant Trial in Patients With Resected PDAC Randomized to Allocation of Oxaliplatin- or Gemcitabine-based Chemotherapy by Standard Clinical Criteria or by a Transcriptomic Treatment Specific Stratification Signature [Phase 3]

See pricing